Agreement expected to upgrade customer payments.
Mural Health, provider of participant management platform Mural Link, announced it will join ProofPilot’s digital protocol automation platform as a partner to improve participant payments.
“At ProofPilot, we have always seen a higher degree of patient compliance when payments can be automated and closely tied to a wide variety of tasks. Most are unaware of the number of hidden activities needed for a patient to execute during a study outside of the explicit tasks,” said Chris Venezia, CEO of ProofPilot. “Through the strategic partnership of our digital protocol automation platform, along with Mural Health’s participant payment capabilities, we will make it easier for our sites and patients to successfully conduct and participate in research by increasing the efficiency to complete tasks, procedures, and now, patient payments.”
Reference: Mural Health and ProofPilot Partner to Streamline Payments and Provide More Patient Choice. Berwyn, PA and New York, NY, USA, MARCH 14, 2023.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.